Ajanta Pharma reports 92% rise in Q3 net profit

27 Jan 2014 Evaluate

Ajanta Pharma has reported results for third quarter ended December 31, 2013.

The company has reported 91.65% rise in its net profit at Rs 62.42 crore for the quarter as compared to Rs 32.57 crore for the same quarter in the previous year. Total income from operations of the company has increased by 31.18% at Rs 300.85 crore for quarter under review as compared to Rs 229.34 crore for the quarter ended December 31, 2012.

Ajanta Pharma is engaged in manufacturing pharmaceutical products. The company runs three divisions -- prescription drugs, OTC and institutional sales.

Ajanta Pharma Share Price

2638.75 12.50 (0.48%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×